REGISTERED NUMBER: 15604578 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

FOR

MEDICAL BRAVO LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

M Wells

REGISTERED OFFICE:

2 Jardine House

Harrovian Business Village

Bessborough Road

Harrow

HA1 3EX

REGISTERED NUMBER:

15604578 (England and Wales)

ACCOUNTANTS:

Barber & Company

A trading name of PCM Accounting Limited

2 Jardine House

Harrovian Business Village

Bessborough Road

Harrow

Middlesex

HA1 3EX

FIXED ASSETS

Property, plant and equipment

4

1,359

-

CURRENT ASSETS

Cash at bank

1,207

1,130

CREDITORS

Amounts falling due within one year

5

199,990

107,322

NET CURRENT LIABILITIES

(198,783

)

(106,192

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(197,424

)

(106,192

)

CAPITAL AND RESERVES

Called up share capital

6

100

100

Retained earnings

7

(197,524

)

(106,292

)

SHAREHOLDERS' FUNDS

(197,424

)

(106,192

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 May 2026 and were signed by:

M Wells - Director

1.	STATUTORY INFORMATION

Medical Bravo Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

During the period under review, the company made a loss after taxation amounting to £91,232 (2025: Loss £106,292).

At 31st March, 2025, the company had Net Current Liabilities, amounting to £198,783 (2025: Liabilities £106,192).

At 31st March, 2026, Creditors: Amounts falling within one year includes £197,716 (2025: £102,438), payable to Medical Bravo d.o.o., a fellow group company registered in Croatia.

The company meets it's day to day working capital requirements with the ongoing support of it's fellow group company, Medical Bravo d.o.o., and it's parent company, Medical Bravo Services Gmbh. The board of directors of Medical Bravo Limited have taken this into account in their decision to prepare the company's Financial Statements on a Going Concern Basis.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on reducing balance

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 1 ) .

4.	PROPERTY, PLANT AND EQUIPMENT

Computer

equipment

£

COST

Additions

2,028

At 31 March 2026

2,028

DEPRECIATION

Charge for year

669

At 31 March 2026

669

NET BOOK VALUE

At 31 March 2026

1,359

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Amounts owed to group undertakings

197,716

102,438

Other creditors

774

3,384

Accruals and deferred income

1,500

1,500

199,990

107,322

6.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.26

31.3.25

value:

£

£

100

ordinary shares

£1

100

100

7.

RESERVES

Retained

earnings

£

At 1 April 2025

(106,292

)

Deficit for the year

(91,232

)

At 31 March 2026

(197,524

)

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Medical Bravo Services Gmbh.

The company's entire issued equity share cxapital is owned by Medical Bravo Services Gmbh, a company registered in Austria.

The address of Medical Bravo Services Gmbh is as follows:

PO Box 1010

7/12 Jordangasse

Wein

Austria